je.st
news
Alimera Sciences: Insiders Buying This Biotech, Stock Sees Catalyst
2015-10-13 08:51:01| Biotech - Topix.net
Alimera Sciences is a bio-pharmaceutical company on the Nasdaq with a market cap of $116 million. The company has developed a product called Iluvien , which was FDA approved in 2014 and made commercially available in the US, UK, Germany and Portugal.
Tags: stock
buying
sciences
sees
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||